Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege
Yi‐Hsien Fang, Saprina P.H. Wang, Zi-Han Gao, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2359-2359
Open Access | Times Cited: 19

Showing 19 citing articles:

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 68
Induced Pluripotent Stem Cell-Derived Cardiomyocytes Therapy for Ischemic Heart Disease in Animal Model: A Meta-Analysis
Quan Duy Vo, Yukihiro Saito, Kazufumi Nakamura, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 987-987
Open Access | Times Cited: 9
Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation
Beatrice Xuan Ho, Adrian Kee Keong Teo, Natasha Hui Jin Ng
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Therapeutic Applications of Extracellular Vesicles for Myocardial Repair
Chunping Liu, Nathan Bayado, Dongyue He, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 34
Cell-Based and Selected Cell-Free Therapies for Myocardial Infarction: How Do They Compare to the Current Treatment Options?
Mária Csöbönyeiová, Nikoleta Beerová, Martin Klein, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10314-10314
Open Access | Times Cited: 21
Small Extracellular Vesicles Derived from Induced Pluripotent Stem Cells in the Treatment of Myocardial Injury
Wan-ting Meng, Hai-dong Guo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4577-4577
Open Access | Times Cited: 12
Amniotic Fluid-Derived Stem Cells: An Overlooked Source of Stem Cells for Translational Research
Yu Jiang, Yanjiao Li, Li Duan, et al.
DNA and Cell Biology (2025) Vol. 44, Iss. 3, pp. 144-152
Closed Access
Stem cell and exosome therapies for regenerating damaged myocardium in heart failure
Roghayeh Yahyazadeh, Vafa Baradaran Rahimi, Vahid Reza Askari
Life Sciences (2024) Vol. 351, pp. 122858-122858
Closed Access | Times Cited: 3
Opportunities and challenges in stem cell therapy in cardiovascular diseases: Position standing in 2022
Shabnur Mahmud, Safaet Alam, Nazim Uddin Emon, et al.
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 9, pp. 1360-1371
Open Access | Times Cited: 13
Induced pluripotent stem cell-based therapies for organ fibrosis
Wei Cheng, Chengming Fan, Qing Song, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 5
Critical Overview on Regenerative Medicine: New Insights into the Role of Stem Cells and Innovative Biomaterials
Marco Tatullo, Barbara Zavan, Adriano Piattelli
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7936-7936
Open Access | Times Cited: 4
The origin, progress, and application of cell‐based cardiac regeneration therapy
Danping Zhuo, Ienglam Lei, Wenjun Li, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 8, pp. 1732-1755
Closed Access | Times Cited: 4
HLA‐Ehigh/HLA‐Ghigh/HLA‐IIlow Human iPSC‐Derived Cardiomyocytes Exhibit Low Immunogenicity for Heart Regeneration
Yi‐Hsien Fang, Saprina P.H. Wang, I‐Chuang Liao, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 29
Open Access | Times Cited: 3
Immunogenicity in Stem Cell Therapy for Cardiac Regeneration.
Yi Fang, Saprina P.H. Wang, Hsien Yuan Chang, et al.
PubMed (2020) Vol. 36, Iss. 6, pp. 588-594
Closed Access | Times Cited: 7
Progress and Challenges of Amniotic Fluid Derived Stem Cells in Therapy of Ischemic Heart Disease
Yi‐Hsien Fang, Saprina P.H. Wang, Hsien‐Yuan Chang, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 102-102
Open Access | Times Cited: 7
Introduction on Stem Cell Therapy and Regeneration
Mahdi Masrour, Aysan Moeinafshar, Nima Rezaei
Elsevier eBooks (2024), pp. 1-23
Closed Access
Transcriptome-wide RNA 5-methylcytosine profiles of human iPSCs and iPSC-derived cardiomyocytes
Szu-Ying Chen, Yi‐Hsien Fang, Chen‐Yu Huang, et al.
Scientific Data (2024) Vol. 11, Iss. 1
Open Access
Optimization and In Vitro Evaluation of Curcumin-loaded Calcium Alginate Microbeads using Box-Behnken Design for Colorectal Cancer
Amit Kumar Pandey, Udaivir Singh Sara, Harinath Dwivedi
Current Indian Science (2023) Vol. 01
Open Access | Times Cited: 1
Amniotic Fluid-Derived Stem Cells: A Promising Resource for Cardiomyogenesis
Sajjad Sisakhtnezhad
Eurasian Journal of Medicine and Oncology (2023)
Open Access
Page 1

Scroll to top